Bentiromide

Bentiromide (CAS No.: 37106-97-1) is a synthetic peptide based research reagent broadly categorized as a protease cleavable functional substrate used to investigate exocrine pancreatic enzyme biology, particularly chymotrypsin associated proteolytic capacity, and it is commonly applied in biochemical and translational laboratory settings focused on digestive enzyme function, assay development, and biomarker oriented drug discovery workflows. Its functional background is rooted in selective peptide bond hydrolysis by serine proteases, with chymotrypsin regarded as the principal enzymatic target in experimental paradigms, and the relevant mechanism is substrate recognition followed by proteolytic cleavage that can be coupled to downstream analytical readouts for enzyme activity profiling, comparative phenotyping, and validation of protease dependent assay systems rather than direct modulation of intracellular receptor signaling networks. Consistent with its role as a diagnostic style research substrate rather than a classical inhibitory or agonist pharmacology tool, publicly summarized potency parameters such as IC50 or EC50 are generally not reported in the same way as for receptor ligands, and in vitro use is therefore typically described through substrate turnover conditions that are commonly established from low micromolar to higher micromolar concentration windows depending on enzyme source, matrix complexity, and detection platform sensitivity. In biomedical research, Bentiromide is used to support mechanistic studies of pancreatic exocrine insufficiency models, to benchmark protease activity assays in cell free systems and biological fluids, and to aid preclinical method development in animal based investigations of digestive enzyme dynamics, while concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, with optimization performed according to assay format, species context, and intended analytical endpoint.